Growth Metrics

Regenerex Pharma (RGPX) Interest Coverage Ratio (2013 - 2025)

Regenerex Pharma (RGPX) reported Interest Coverage Ratio of 196.68 for Q3 2025, down 20159.39% year-over-year from N/an in Q3 2024, and down 632.24% on a QoQ basis from 26.86 in Q2 2025.

Regenerex Pharma (RGPX) has 9 years of Interest Coverage Ratio data on file, last reported at 196.68 in Q3 2025.

  • Quarterly Interest Coverage Ratio fell 20159.39% year-over-year to 196.68 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 7.63 (down 185.95% YoY) and the FY2025 annual result came in at 5.71, up 86.72% from the prior year.
  • Interest Coverage Ratio retreated to 196.68 in Q3 2025 per RGPX's latest filing, from 26.86 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.43 in Q1 2023 and bottomed at 196.68 in Q3 2025.
  • The 5-year median for Interest Coverage Ratio is 3.44 (2024), against an average of 23.81.
  • The widest annual swing landed in 2024, when Interest Coverage Ratio jumped 99.31%; it then sank 20159.39% in 2025.
  • Tracing RGPX's Interest Coverage Ratio over 5 years: stood at 4.26 in 2021, then surged by 60.38% to 1.69 in 2022, then slumped by 601.42% to 11.84 in 2023, then climbed by 2.61% to 11.53 in 2024, then tumbled by 1605.7% to 196.68 in 2025.
  • Per Business Quant, the three latest RGPX Interest Coverage Ratio figures stand at 196.68 (Q3 2025), 26.86 (Q2 2025), and 3.3 (Q1 2025).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -196.68
Jun 30, 2025 -26.86
Mar 31, 2025 -3.30
Dec 31, 2024 -11.53
Sep 30, 2024 -0.97
Jun 30, 2024 -11.39
Mar 31, 2024 -3.59
Dec 31, 2023 -11.84
Sep 30, 2023 -140.70
Jun 30, 2023 -8.66
Mar 31, 2023 -0.43
Dec 31, 2022 -1.69
Sep 30, 2022 -1.29
Jun 30, 2022 -1.11
Mar 31, 2022 -2.11
Dec 31, 2021 -4.26
Sep 30, 2021 -1.25
Jun 30, 2021 -0.92
Dec 31, 2020 -1.27
Sep 30, 2020 -1.11
Jun 30, 2020 -1.08
Dec 31, 2019 -1.57
Sep 30, 2019 -1.72
Mar 31, 2019 -0.53
Aug 31, 2014 -1.94
May 31, 2014 239.34
Aug 31, 2013 -223.19
May 31, 2013 280.86